Sign up to save your podcasts
Or
Share 230: BIO's messy transition, mRNA's future, & Biogen's next CEO
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
230: BIO's messy transition, mRNA's future, & Biogen's next CEO
STAT Washington correspondent Rachel Cohrs joins us to explain the abrupt departure of the CEO of BIO, the lobbying group representing biotech on Capitol Hill, and its wider implications. We also discuss the latest news in the life sciences, including the future of mRNA, a promising startup closing its doors, and Biogen’s search for a new CEO.
View all episodes
By STAT
4.5
309309 ratings
STAT Washington correspondent Rachel Cohrs joins us to explain the abrupt departure of the CEO of BIO, the lobbying group representing biotech on Capitol Hill, and its wider implications. We also discuss the latest news in the life sciences, including the future of mRNA, a promising startup closing its doors, and Biogen’s search for a new CEO.
More shows like The Readout Loud
View all
Planet Money
30,672 Listeners
Odd Lots
1,898 Listeners
What the Health? From KFF Health News
498 Listeners
The Indicator from Planet Money
9,525 Listeners
The Journal.
6,076 Listeners
Tradeoffs
395 Listeners
Biotech 2050 Podcast
61 Listeners
Business Of Biotech
86 Listeners
BioCentury This Week
34 Listeners
Dwarkesh Podcast
505 Listeners
Hard Fork
5,475 Listeners
Biotech Hangout
19 Listeners
Ground Truths
48 Listeners
Money Stuff: The Podcast
387 Listeners
The BioCentury Show
12 Listeners